BOTHELL, Wash.--(BUSINESS WIRE)--
- Approval of Supplemental New Drug Submission for ADCETRIS in Combination with CHP Chemotherapy in Frontline CD30-Expressing Peripheral T-Cell Lymphoma based on Positive Phase 3 ECHELON-2 Clinical Trial Results -
Seattle Genetics, Inc. (SGEN) today announced that Health Canada has approved the supplemental New Drug Submission that expands the use of ADCETRIS (brentuximab vedotin) in combination with CHP (cyclophosphamide, doxorubicin, prednisone) chemotherapy for the treatment of previously untreated adult patients with systemic anaplastic large cell lymphoma (sALCL), peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS) or angioimmunoblastic T-cell lymphoma (AITL), whose tumours express CD30. The approval is based on positive results of the phase 3 ECHELON-2 clinical trial that compared ADCETRIS plus CHP to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Health Canada granted a Priority Review Designation for this submission. ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, which is expressed on the surface of several types of PTCL.
The Health Canada approval of ADCETRIS (brentuximab vedotin) in combination with CHP chemotherapy in newly diagnosed CD30-expressing peripheral T-cell lymphoma represents the first major advance for Canadian patients with PTCL in decades, said Kerry Savage, M.D., Medical Oncologist at the BC Cancer Agency, Professor of Medicine at the University of British Columbia and investigator on the ECHELON-2 clinical trial. The approval is based on the ECHELON-2 clinical trial that demonstrated ADCETRIS (brentuximab vedotin) plus CHP regimen was superior for both progression-free survival and all key secondary endpoints, including overall survival, when compared to the standard of care CHOP chemotherapy.
The current standard of care for initial treatment of peripheral T-cell lymphoma is multi-agent chemotherapy, which results in low complete remission rates and poor progression-free and overall survival. ECHELON-2 is the first randomized trial to demonstrate an overall survival benefit over established standard therapy, making it a meaningful advance in the treatment of these rare lymphomas, said Roger Dansey, M.D., Chief Medical Officer at Seattle Genetics. With this new indication for ADCETRIS, physicians and eligible patients in Canada now have access to this important new regimen for treating frontline CD30-expressing peripheral T-cell lymphoma, another milestone supporting our plans to continue to expand ADCETRIS globally to patients in need.
In May 2019, Health Canada approved the supplemental New Drug Submission that expanded the use of ADCETRIS in combination with AVD (Adriamycin, vinblastine and dacarbazine) chemotherapy in patients with previously untreated Stage IV Hodgkin lymphoma (HL) based on the results of the phase 3 ECHELON-1 clinical trial.
About T-Cell Lymphomas
There are more than 60 subtypes of non-Hodgkin lymphomas which are broadly divided into two major groups: B-cell lymphomas, which develop from abnormal B-lymphocytes, and T-cell lymphomas, which develop from abnormal T-lymphocytes. There are many different forms of T-cell lymphomas, some of which are extremely rare. T-cell lymphomas can be aggressive (fast-growing) or indolent (slow-growing). PTCL accounts for approximately 10 percent of non-Hodgkin lymphoma cases in the U.S. and Europe and may be as high as 24 percent in parts of Asia.
About ADCETRIS
ADCETRIS is being evaluated broadly in more than 70 clinical trials in CD30-expressing lymphomas. These include three completed phase 3 trials: ECHELON-2 trial in frontline peripheral T-cell lymphomas, ECHELON-1 in previously untreated Hodgkin lymphoma, and ALCANZA in cutaneous T-cell lymphoma.
ADCETRIS is an ADC comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seattle Genetics proprietary technology. The ADC employs a linker system that is designed to be stable in the bloodstream but to release MMAE upon internalization into CD30-expressing tumor cells.
ADCETRIS injection for intravenous infusion has received FDA approval for six indications in adult patients with: (1) previously untreated systemic anaplastic large cell lymphoma (sALCL) or other CD30-expressing peripheral T-cell lymphomas (PTCL), including angioimmunoblastic T-cell lymphoma and PTCL not otherwise specified, in combination with cyclophosphamide, doxorubicin, and prednisone, (2) previously untreated Stage III or IV classical Hodgkin lymphoma (cHL), in combination with doxorubicin, vinblastine, and dacarbazine, (3) cHL at high risk of relapse or progression as post-autologous hematopoietic stem cell transplantation (auto-HSCT) consolidation, (4) cHL after failure of auto-HSCT or failure of at least two prior multi-agent chemotherapy regimens in patients who are not auto-HSCT candidates, (5) sALCL after failure of at least one prior multi-agent chemotherapy regimen, and (6) primary cutaneous anaplastic large cell lymphoma (pcALCL) or CD30-expressing mycosis fungoides (MF) who have received prior systemic therapy.
Story continues
Health Canada granted ADCETRIS approval with conditions in 2013 for patients with (1) HL after failure of autologous stem cell transplant (ASCT) or after failure of at least two multi-agent chemotherapy regimens in patients who are not ASCT candidates and (2) sALCL after failure of at least one multi-agent chemotherapy regimen. Non-conditional approval was granted for (3) post-ASCT consolidation treatment of patients with HL at increased risk of relapse or progression in 2017, (4) adult patients with pcALCL or CD30-expressing MF who have received prior systemic therapy in 2018, (5) for previously untreated patients with Stage IV HL in combination with doxorubicin, vinblastine, and dacarbazine in 2019, and (6) for previously untreated adult patients with sALCL, peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS) or angioimmunoblastic T-cell lymphoma (AITL), whose tumors express CD30, in combination with cyclophosphamide, doxorubicin, prednisone in 2019.
ADCETRIS received conditional marketing authorization from the European Commission in October 2012. The approved indications in Europe are: (1) for the treatment of adult patients with relapsed or refractory CD30-positive Hodgkin lymphoma following ASCT, or following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option, (2) for the treatment of adult patients with relapsed or refractory sALCL, (3) for the treatment of adult patients with CD30-positive Hodgkin lymphoma at increased risk of relapse or progression following ASCT, (4) for the treatment of adult patients with CD30-positive cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy and (5) for the treatment of adult patients with previously untreated CD30-positive Stage IV Hodgkin lymphoma in combination with AVD (Adriamycin, vinblastine and dacarbazine).
ADCETRIS has received marketing authorization by regulatory authorities in 73 countries for relapsed or refractory Hodgkin lymphoma and sALCL. See select important safety information, including Boxed Warning, below.
Seattle Genetics and Takeda are jointly developing ADCETRIS. Under the terms of the collaboration agreement, Seattle Genetics has U.S. and Canadian commercialization rights and Takeda has rights to commercialize ADCETRIS in the rest of the world. Seattle Genetics and Takeda are funding joint development costs for ADCETRIS on a 50:50 basis, except in Japan where Takeda is solely responsible for development costs.
About Seattle Genetics
Seattle Genetics, Inc. is an emerging multi-product, global biotechnology company that develops and commercializes transformative therapies targeting cancer to make a meaningful difference in peoples lives. ADCETRIS (brentuximab vedotin) utilizes the companys industry-leading antibody-drug conjugate (ADC) technology and is currently approved for the treatment of multiple CD30-expressing lymphomas. Beyond ADCETRIS, the company has a late-stage pipeline including enfortumab vedotin for metastatic urothelial cancer, currently being reviewed for approval by the FDA, and tisotumab vedotin in clinical trials for metastatic cervical cancer, which utilize our proprietary ADC technology. In addition, tucatinib, a small molecule tyrosine kinase inhibitor, is in late-stage development for HER2-positive metastatic breast cancer and in clinical development for metastatic colorectal cancer. We are also leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials targeting hematologic malignancies and solid tumors. The company is headquartered in Bothell, Washington, and has a European office in Switzerland. For more information on our robust pipeline, visit http://www.seattlegenetics.com and follow @SeattleGenetics on Twitter.
ADCETRIS (brentuximab vedotin) U.S. Important Safety Information
BOXED WARNING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML): JC virus infection resulting in PML and death can occur in ADCETRIS-treated patients.
Contraindication
ADCETRIS concomitant with bleomycin due to pulmonary toxicity (e.g., interstitial infiltration and/or inflammation).
Warnings and Precautions
Most Common (20% in any study) Adverse Reactions: Peripheral neuropathy, fatigue, nausea, diarrhea, neutropenia, upper respiratory tract infection, pyrexia, constipation, vomiting, alopecia, decreased weight, abdominal pain, anemia, stomatitis, lymphopenia and mucositis.
Drug Interactions
Concomitant use of strong CYP3A4 inhibitors or inducers has the potential to affect the exposure to monomethyl auristatin E (MMAE).
Use in Specific Populations
Moderate or severe hepatic impairment or severe renal impairment: MMAE exposure and adverse reactions are increased. Avoid use.
Advise males with female sexual partners of reproductive potential to use effective contraception during ADCETRIS treatment and for at least 6 months after the final dose of ADCETRIS.
Advise patients to report pregnancy immediately and avoid breastfeeding while receiving ADCETRIS.
Please see the full Prescribing Information, including BOXED WARNING, for ADCETRIS here.
Forward-Looking Statements
Certain of the statements made in this press release are forward looking, such as those, among others, relating to the potential utilization of ADCETRIS (brentuximab vedotin) for previously untreated adult patients with systemic anaplastic large cell lymphoma, peripheral T-cell lymphoma-not otherwise specified or angioimmunoblastic T-cell lymphoma, whose tumours express CD30 in Canada and the therapeutic potential of ADCETRIS in this indication. Actual results or developments may differ materially from those projected or implied in these forward-looking statements due to factors such as utilization and adoption of the approved treatment regimen by prescribing physicians, competitive conditions including the availability of alternative treatment regimens, the availability and extent of reimbursement, the risk of adverse events, and adverse regulatory action. More information about the risks and uncertainties faced by Seattle Genetics is contained under the caption Risk Factors included in the companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 filed with the Securities and Exchange Commission. Seattle Genetics disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191125005237/en/
- SIRA: Could Stem Cell Therapy Renew Your Body Cells? - Private ... [Last Updated On: April 23rd, 2011] [Originally Added On: April 23rd, 2011]
- Stem Cell Series: Part 1 [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Huntington's Disease: Stem Cell Treatment Strategies at UC Davis [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Tianjin heart hospital the largest in Asia with stem cell treatment as well.mp4 [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Researchers hope stem cell treatment can improve heart healing [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Testimonial for Fetal Stem Cell Treatment of Duchenne Muscular Dystrophy [Last Updated On: August 5th, 2011] [Originally Added On: August 5th, 2011]
- MS Views and News Podcast - Stem Cell Treatment [Last Updated On: August 6th, 2011] [Originally Added On: August 6th, 2011]
- Duchenne's Muscular Dystrophy Stem Cell Treatment - Reelabs India [Last Updated On: August 7th, 2011] [Originally Added On: August 7th, 2011]
- Stem cell treatment for Macular Degeneration - Graham Leach [Last Updated On: August 7th, 2011] [Originally Added On: August 7th, 2011]
- The New World of Medicine: Stem Cell Therapy [Last Updated On: August 8th, 2011] [Originally Added On: August 8th, 2011]
- Stem Cell Treatment for Cerebral Palsy (Periventricular Leukomalacia) [Last Updated On: August 8th, 2011] [Originally Added On: August 8th, 2011]
- Medra Inc - Breakthrough Stem Cell Treatment [Last Updated On: August 9th, 2011] [Originally Added On: August 9th, 2011]
- Patricia VS Autism: Adult Stem Cell Treatment Part 1 [Last Updated On: August 10th, 2011] [Originally Added On: August 10th, 2011]
- Stem Cell Treatment for Multiple Sclerosis - Community Outreach San Diego: Xenia C. [Last Updated On: August 10th, 2011] [Originally Added On: August 10th, 2011]
- Stem Cell Treatment for Cerebral Palsy at the XCell-Center in Germany [Last Updated On: August 11th, 2011] [Originally Added On: August 11th, 2011]
- Bone Marrow Aspiration - Stem Cell Therapy [Last Updated On: August 13th, 2011] [Originally Added On: August 13th, 2011]
- Dr. William Rader - Breakthrough Stem Cell Treatment [Last Updated On: August 13th, 2011] [Originally Added On: August 13th, 2011]
- Clinical Advances in Adult Stem Cell Therapy - Dr. Jorge Paz Rodriguez (Miami) [Last Updated On: August 14th, 2011] [Originally Added On: August 14th, 2011]
- Stem cell treatment on horse a success, vet says [Last Updated On: August 15th, 2011] [Originally Added On: August 15th, 2011]
- Patricia VS Autism: Adult Stem Cell Treatment Part 2 [Last Updated On: August 15th, 2011] [Originally Added On: August 15th, 2011]
- Adult Stem Cell Therapy Clinical Advances - Dr. Jorge Paz in San Diego, CA March 2011 [Last Updated On: August 17th, 2011] [Originally Added On: August 17th, 2011]
- Dr. Ulrich Friedrichson, Geneticist, and Stem Cell Therapy pioneer [Last Updated On: August 19th, 2011] [Originally Added On: August 19th, 2011]
- Bone Marrow Stem Cells/Gene Therapy [Last Updated On: August 19th, 2011] [Originally Added On: August 19th, 2011]
- Regenerative Medicine With Stem Cell Therapy Injections at an Arizona pain clinic (602) 507-6550 [Last Updated On: August 19th, 2011] [Originally Added On: August 19th, 2011]
- Diabetes - Stem Cell Treatment [Last Updated On: August 21st, 2011] [Originally Added On: August 21st, 2011]
- Stem Cell Treatments for Autism: Community Outreach Miami, Florida - Juliana Ubinas [Last Updated On: August 22nd, 2011] [Originally Added On: August 22nd, 2011]
- Post Stem Cell Therapy Testimony of Cerebral Palsy [Last Updated On: August 26th, 2011] [Originally Added On: August 26th, 2011]
- VetCell's StemRegen - the original and best stem cell therapy for equine tendon injuries [Last Updated On: August 26th, 2011] [Originally Added On: August 26th, 2011]
- Stem cell treatment cures blind girl. More at http://www.stemcellfusion.com [Last Updated On: August 30th, 2011] [Originally Added On: August 30th, 2011]
- ALS Patient Interview, Stem Cell Treatments and ALS www.stemcellregenmed.com [Last Updated On: September 1st, 2011] [Originally Added On: September 1st, 2011]
- Stem Cell Treatment for Rheumatoid Arthritis - "I got my life back" [Last Updated On: September 1st, 2011] [Originally Added On: September 1st, 2011]
- Stem Cell Treatment for Autism: Community Outreach Miami, Florida - May 2011 [Last Updated On: September 2nd, 2011] [Originally Added On: September 2nd, 2011]
- Rylea returns home after stem cell treatment in China [Last Updated On: September 3rd, 2011] [Originally Added On: September 3rd, 2011]
- Stem Cell Treatments and ALS - www.StemCellRegenMed.com [Last Updated On: September 4th, 2011] [Originally Added On: September 4th, 2011]
- Patient with ALS Receiving Stem Cell Treatment - www.StemCellRegenMed.com [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- Stem Cell Therapy Success [Last Updated On: September 6th, 2011] [Originally Added On: September 6th, 2011]
- Lisa Ray Opens Up About Her Stem Cell Treatment Experience [Last Updated On: September 17th, 2011] [Originally Added On: September 17th, 2011]
- Repair Your Joint Injuries With Stem Cell Therapy | Los Angeles | Beverly Hills | Hollywood [Last Updated On: September 18th, 2011] [Originally Added On: September 18th, 2011]
- What could stem cell therapy do for Peyton? [Last Updated On: September 21st, 2011] [Originally Added On: September 21st, 2011]
- Peyton Manning Stem Cell Therapy: Some Doctors Cry Foul Over European Treatment [Last Updated On: September 22nd, 2011] [Originally Added On: September 22nd, 2011]
- Adickes: Stem cell therapy [Last Updated On: September 27th, 2011] [Originally Added On: September 27th, 2011]
- Webinar 1, Stem cell therapy basics, what is available today? [Last Updated On: September 30th, 2011] [Originally Added On: September 30th, 2011]
- Stem Cell Treatment for Leukemia at UCH [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- Testimonial 4 of Duchenne Muscular Dystrophy after Stem Cell Therapy [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- The Spinal Cord Journey - Stem cell therapy stories from three spinal cord injury patients [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- Parkinson Stem Cell Treatment [Last Updated On: October 7th, 2011] [Originally Added On: October 7th, 2011]
- " Embryonic" and "Adult" Stem Cell Research explained by David Kupelian [Last Updated On: October 11th, 2011] [Originally Added On: October 11th, 2011]
- Stem Cell Treatment for Heart Failure [Last Updated On: October 12th, 2011] [Originally Added On: October 12th, 2011]
- Stem Cell Therapy for Sickle Cell Anemia - Video [Last Updated On: October 14th, 2011] [Originally Added On: October 14th, 2011]
- Stem Cell Therapy Skin Repair and Anti-Wrinkle Cream - Video [Last Updated On: October 14th, 2011] [Originally Added On: October 14th, 2011]
- Stem Cell Treatment for Multiple Sclerosis - Community Outreach, San Diego: David Oliver - Video [Last Updated On: October 15th, 2011] [Originally Added On: October 15th, 2011]
- Spinal Cord Injury Patient after Stem Cell Treatment - Juan Carlos Murillo - Video [Last Updated On: October 16th, 2011] [Originally Added On: October 16th, 2011]
- Macular degeneration - Stem Cell therapy (English subtitles) - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- stem cell research - Video [Last Updated On: October 18th, 2011] [Originally Added On: October 18th, 2011]
- Diabetes- Stem cell therapy (english) - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- First Spinal-Cord Surgery With Stem Cells - Video [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- The Skin Gun - Video [Last Updated On: October 23rd, 2011] [Originally Added On: October 23rd, 2011]
- Heart Congestion Failure- stem cell therapy (english) - Video [Last Updated On: October 24th, 2011] [Originally Added On: October 24th, 2011]
- Improvement seen in Duchenne Muscular Dystrophy after Stem Cell Therapy - Video [Last Updated On: October 24th, 2011] [Originally Added On: October 24th, 2011]
- Joseph, Friedreich's Ataxia, before stem cell treatment at Tiantan Puhua Hospital Beijing - Video [Last Updated On: October 25th, 2011] [Originally Added On: October 25th, 2011]
- Ataxia - Stem Cell Treatment TV Special (Part 1) - Video [Last Updated On: October 25th, 2011] [Originally Added On: October 25th, 2011]
- COPD and Stem Cell Treatments - www.StemCellRegenMed.com - Video [Last Updated On: October 26th, 2011] [Originally Added On: October 26th, 2011]
- Rheumatoid Arthritis Stem Cell Treatment - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- Stem Cells Repair Joint Cartilage - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- Soon stem cell cure for hearing loss - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- Extra: The Promise of Stem Cell Treatment - Video [Last Updated On: October 28th, 2011] [Originally Added On: October 28th, 2011]
- Batten Disease: Spotlight on Stem Cell Research - A Father's Story - Video [Last Updated On: October 28th, 2011] [Originally Added On: October 28th, 2011]
- Stem cell treatment by Adiva Health Care India after Spinal Cord Injury - Video [Last Updated On: October 29th, 2011] [Originally Added On: October 29th, 2011]
- Macular Degeneration: Spotlight on Stem Cell Research - Mark Humayun - Video [Last Updated On: October 29th, 2011] [Originally Added On: October 29th, 2011]
- Stem Cells to Treat Acne Scarring | Los Angeles | Hollywood | Beverly Hills - Video [Last Updated On: October 30th, 2011] [Originally Added On: October 30th, 2011]
- Stem Cell Treatment Kidney Failure - Video [Last Updated On: November 5th, 2011] [Originally Added On: November 5th, 2011]
- Stem Cell Miracle From Cord Blood - Video [Last Updated On: November 7th, 2011] [Originally Added On: November 7th, 2011]
- Stem Cell Therapy: Psoriatic Arthritis Treatment - Video [Last Updated On: November 8th, 2011] [Originally Added On: November 8th, 2011]
- Deafness: Spotlight on Stem Cell Research - Karen Doyle - Video [Last Updated On: November 9th, 2011] [Originally Added On: November 9th, 2011]
- Daniel Deeter Testimonial for Fetal Stem Cell Treatment at Kyiv, Ukraine - Video [Last Updated On: November 12th, 2011] [Originally Added On: November 12th, 2011]
- Stem Cell Treatment Fibromyalgia - Video [Last Updated On: November 13th, 2011] [Originally Added On: November 13th, 2011]
- Stem Cell Treatment Kidney Disease - Video [Last Updated On: November 14th, 2011] [Originally Added On: November 14th, 2011]
- Heart patient sees results in stem cell study - Video [Last Updated On: November 15th, 2011] [Originally Added On: November 15th, 2011]
- Heart health: Patient's own stem cells repaired damage - Video [Last Updated On: November 15th, 2011] [Originally Added On: November 15th, 2011]
- StemCellTV Daily Report-November 15, 2011 - Video [Last Updated On: November 16th, 2011] [Originally Added On: November 16th, 2011]